Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001021408-02-002691
Filing Date
2002-02-21
Accepted
2002-02-21 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k405.txt 10-K405 327410
3 EMPLOYMENT AGREEMENT dex10176.txt EX-10.176 16390
4 EMPLOYMENT AGREEMENT dex10177.txt EX-10.177 16738
5 SECOND AMENDMENT dex10178.txt EX-10.178 4471
6 SUBSIDIARIES dex21.txt EX-21 6472
7 CONSENT OF INDEPENDENT ACCOUNTANTS dex231.txt EX-23.1 639
  Complete submission text file 0001021408-02-002691.txt   374198
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-27570 | Film No.: 02555098
SIC: 8731 Services-Commercial Physical & Biological Research